Retinopathy of prematurity in the United Kingdom: retreatment rates, visual and structural 1-year outcomes.

Eye
Gillian G W AdamsUK Retinopathy of Prematurity Special Interest Group

Abstract

To evaluate retreatment rates, visual and anatomical outcomes at 1-year postnatal age in infants treated for retinopathy of prematurity (ROP) METHODS: Longitudinal national surveillance study of infants treated for ROP in the United Kingdom between December 2013 and December 2014, supported by the British Ophthalmic Surveillance Unit. Here we report retreatment rates, anatomical, visual and refractive outcomes at 1-year follow-up. One-year follow-up forms were completed for 168 children of the original cohort of 327 (51.4%). Twenty-two had at least one retreatment: 17/153 right eyes (REs, 11.1%) after initial diode laser, and 5/14 REs (35.7%) after initial injection of anti-vascular endothelial growth factor (VEGF) antibody. Median (interquartile range) RE best-corrected visual acuity was 0.6 (0.4-1.0) (n = 46 REs), and median acuity both eyes open 0.4 (0.3-0.7) logMAR (n = 89). Median spherical equivalent (RE) was 0.44 (-1.3 to 1.3) dioptre (D) (n = 116). Median astigmatism (RE) was 0.5 (0-1.0) D (n = 111), and median anisometropia 0.125 (0-0.75) D (n = 116). Twenty-four children (20.5%) had been prescribed glasses. Sight impairment certification eligibility information was available for 131 children: 11 (8.4%) were eligible t...Continue Reading

References

Sep 1, 1990·Optometry and Vision Science : Official Publication of the American Academy of Optometry·M L Courage, R J Adams
Aug 20, 2002·The British Journal of Ophthalmology·K J SaundersA G Wilkinson
Dec 10, 2003·Archives of Ophthalmology·UNKNOWN Early Treatment For Retinopathy Of Prematurity Cooperative Group
Jul 19, 2005·Ophthalmology·Bradley V DavittUNKNOWN Early Treatment for Retinopathy of Prematurity Cooperative Group
Apr 22, 2008·Ophthalmology·Graham E QuinnUNKNOWN Early Treatment for Retinopathy of Prematurity Cooperative Group
Dec 19, 2008·Ophthalmology·Bradley V DavittUNKNOWN Early Treatment for Retinopathy of Prematurity Cooperative Group
Feb 18, 2011·The New England Journal of Medicine·Helen A Mintz-HittnerUNKNOWN BEAT-ROP Cooperative Group
May 17, 2012·Investigative Ophthalmology & Visual Science·Li Deng, Jane E Gwiazda
Sep 12, 2013·Acta Ophthalmologica·Björn C HarderFrank C Schlichtenbrede
Aug 12, 2014·JAMA Ophthalmology·Megan M GeloneckUNKNOWN BEAT-ROP Cooperative Group
Mar 13, 2016·The British Journal of Ophthalmology·Gerd HolmströmAgneta Wallin
Dec 16, 2016·Ophthalmic Surgery, Lasers & Imaging Retina·Tsengelmaa ChuluunbatWei-Chi Wu

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02375971

Software Mentioned

EPICURE
Office Access

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.